T1	ANAT 25 31	sérica
#1	AnnotatorNotes T1	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T3	PROC 138 150	hemodiálisis
#2	AnnotatorNotes T3	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T4	DISO 185 210	anomalías minerales óseas
T5	CHEM 195 204	minerales
#3	AnnotatorNotes T5	C0026162; Minerals; Inorganic Chemical
T6	ANAT 205 210	óseas
#4	AnnotatorNotes T6	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T7	ANAT 230 244	cardiovascular
#5	AnnotatorNotes T7	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T8	ANAT 293 307	cardiovascular
#6	AnnotatorNotes T8	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T9	DISO 325 349	enfermedad renal crónica
#7	AnnotatorNotes T9	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T10	DISO 351 354	ERC
#8	AnnotatorNotes T10	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T11	DISO 33 46	calcificación
#9	AnnotatorNotes T11	C0006663; Calcinosis; Pathologic Function
T12	DISO 425 455	patogenia del metabolismo óseo
T13	ANAT 451 455	óseo
#10	AnnotatorNotes T13	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T14	ANAT 475 483	vascular
#11	AnnotatorNotes T14	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T15	CHEM 507 516	inhibidor
#12	AnnotatorNotes T15	C1999216; Inhibitor; Biologically Active Substance
T16	ANAT 626 630	óseo
#13	AnnotatorNotes T16	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T17	ANAT 653 661	vascular
#14	AnnotatorNotes T17	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T18	DISO 679 682	ERC
#15	AnnotatorNotes T18	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T19	PROC 836 848	hemodiálisis
#16	AnnotatorNotes T19	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T20	PROC 938 963	análisis de supervivencia
#17	AnnotatorNotes T20	C0038953; Survival Analysis; Research Activity
T21	PROC 984 996	hemodiálisis
#18	AnnotatorNotes T21	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T22	ANAT 1111 1132	fístula arteriovenosa
#19	AnnotatorNotes T22	C0729581; Surgical arteriovenous fistula; Body Part, Organ, or Organ Component
T23	ANAT 1071 1077	sérica
#20	AnnotatorNotes T23	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T24	DISO 1622 1635	calcificación
#21	AnnotatorNotes T24	C0006663; Calcinosis; Pathologic Function
T25	DISO 1091 1104	calcificación
#22	AnnotatorNotes T25	C0006663; Calcinosis; Pathologic Function
T26	PROC 1155 1188	escáner tomográfico computarizado
#23	AnnotatorNotes T26	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T27	PROC 1242 1253	seguimiento
#24	AnnotatorNotes T27	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T28	ANAT 1356 1362	sérica
#25	AnnotatorNotes T28	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T29	ANAT 1454 1460	sérica
#26	AnnotatorNotes T29	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T30	CHEM 752 764	esclerostina
#27	AnnotatorNotes T30	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T31	PROC 1677 1700	niveles de esclerostina
#28	AnnotatorNotes T31	C3887493; Sclerostin Measurement; Laboratory Procedure
T32	CHEM 2258 2270	esclerostina
#29	AnnotatorNotes T32	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T33	PROC 1583 1602	valores de albúmina
#30	AnnotatorNotes T33	C0201838; Albumin measurement; Laboratory Procedure
T34	CHEM 1594 1602	albúmina
#31	AnnotatorNotes T34	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T35	ANAT 1642 1663	fístula arteriovenosa
#32	AnnotatorNotes T35	C0729581; Surgical arteriovenous fistula; Body Part, Organ, or Organ Component
T36	CHEM 1688 1700	esclerostina
#33	AnnotatorNotes T36	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T37	PROC 1782 1811	hemodiálisis de mantenimiento
#34	AnnotatorNotes T37	C4040576; Maintenance hemodialysis; Therapeutic or Preventive Procedure
T38	PROC 1842 1859	estudios clínicos
#35	AnnotatorNotes T38	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T39	PROC 1867 1878	seguimiento
#36	AnnotatorNotes T39	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T40	ANAT 1946 1952	sérica
#37	AnnotatorNotes T40	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T41	PROC 1995 2024	hemodiálisis de mantenimiento
#38	AnnotatorNotes T41	C4040576; Maintenance hemodialysis; Therapeutic or Preventive Procedure
T42	PROC 2050 2064	ensayo clínico
#39	AnnotatorNotes T42	C0008976; Clinical Trials; Research Activity
T43	CHEM 1933 1945	esclerostina
#40	AnnotatorNotes T43	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T44	PROC 2172 2209	ensayo prospectivo de un único centro
T45	ANAT 2271 2277	sérica
#41	AnnotatorNotes T45	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T46	ANAT 2319 2340	fístula arteriovenosa
#42	AnnotatorNotes T46	C0729581; Surgical arteriovenous fistula; Body Part, Organ, or Organ Component
T47	ANAT 53 74	fístula arteriovenosa
#43	AnnotatorNotes T47	C0729581; Surgical arteriovenous fistula; Body Part, Organ, or Organ Component
T48	DISO 216 244	calcificación cardiovascular
#44	AnnotatorNotes T48	C4023128; Cardiovascular calcification; Pathologic Function
T49	ANAT 336 341	renal
#45	AnnotatorNotes T49	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T50	DISO 461 483	calcificación vascular
#46	AnnotatorNotes T50	C0342649; Vascular calcification; Disease or Syndrome
T51	DISO 639 661	calcificación vascular
#47	AnnotatorNotes T51	C0342649; Vascular calcification; Disease or Syndrome
T53	DISO 1255 1263	murieron
#48	AnnotatorNotes T53	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T54	DISO 1302 1310	murieron
#49	AnnotatorNotes T54	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T55	CHEM 1343 1355	esclerostina
#50	AnnotatorNotes T55	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T56	PROC 1922 1952	niveles de esclerostina sérica
T58	PROC 2247 2277	niveles de esclerostina sérica
T59	DISO 2283 2296	calcificación
#51	AnnotatorNotes T59	C0006663; Calcinosis; Pathologic Function
T60	CHEM 12 24	esclerostina
#52	AnnotatorNotes T60	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T61	PROC 1 31	Niveles de esclerostina sérica
T62	CHEM 488 500	esclerostina
#53	AnnotatorNotes T62	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T63	CHEM 551 554	Wnt
#54	AnnotatorNotes T63	C0753137; Wnt Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T64	PROC 1047 1077	niveles de esclerostina sérica
T65	CHEM 1058 1070	esclerostina
#55	AnnotatorNotes T65	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T66	PROC 729 764	niveles circulantes de esclerostina
#56	AnnotatorNotes T66	C3887493; Sclerostin Measurement; Laboratory Procedure
T67	PROC 1332 1362	niveles de esclerostina sérica
T68	PROC 1441 1460	esclerostina sérica
T69	CHEM 1441 1453	esclerostina
#57	AnnotatorNotes T69	C3542926; Sclerostin; Amino Acid, Peptide, or Protein
T70	CHEM 415 418	Wnt
#58	AnnotatorNotes T70	C0753137; Wnt Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T72	Duration 111 121	los 2 años
T73	LIVB 125 134	pacientes
#59	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T75	LIVB 311 320	pacientes
#60	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T76	Duration 342 349	crónica
#61	AnnotatorNotes T76	C0205191; chronic; Temporal Concept
T77	PHYS 395 414	vía de señalización
#62	AnnotatorNotes T77	C0037080; Signal Pathways; Molecular Function
T78	PHYS 439 455	metabolismo óseo
#63	AnnotatorNotes T78	C0596204; bone metabolism; Organ or Tissue Function
T80	PHYS 531 550	vía de señalización
#64	AnnotatorNotes T80	C0037080; Signal Pathways; Molecular Function
T81	PHYS 617 630	recambio óseo
#65	AnnotatorNotes T81	C0085268; Bone remodeling; Organ or Tissue Function
T83	LIVB 665 674	pacientes
#66	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T85	LIVB 823 832	pacientes
#67	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T86	Duration 921 929	24 meses
T87	LIVB 971 980	pacientes
#68	AnnotatorNotes T87	C0030705; Patients; Patient or Disabled Group
T90	LIVB 1267 1276	pacientes
#69	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T91	LIVB 1288 1297	pacientes
#70	AnnotatorNotes T91	C0030705; Patients; Patient or Disabled Group
T92	LIVB 1404 1413	pacientes
#71	AnnotatorNotes T92	C0030705; Patients; Patient or Disabled Group
T95	LIVB 1769 1778	pacientes
#72	AnnotatorNotes T95	C0030705; Patients; Patient or Disabled Group
T97	LIVB 1982 1991	pacientes
#73	AnnotatorNotes T97	C0030705; Patients; Patient or Disabled Group
T98	LIVB 2143 2152	pacientes
#74	AnnotatorNotes T98	C0030705; Patients; Patient or Disabled Group
T100	DEVI 1155 1162	escáner
#75	AnnotatorNotes T100	C0183115; Scanning Systems; Medical Device
T71	Date 2363 2367	2015
T74	PROC 2101 2109;2119 2135	análisis de supervivencia
#76	AnnotatorNotes T74	C0038953; Survival Analysis; Research Activity
T79	Spec_cue 722 724	si
A1	Assertion T66 Speculated
R1	Speculation Arg1:T79 Arg2:T66	
A2	Assertion T30 Speculated
T82	Quantifier_or_Qualifier 771 780	asociados
A3	Assertion T82 Speculated
#77	AnnotatorNotes T82	C0332281; Associated with; Qualitative Concept
R2	Speculation Arg1:T79 Arg2:T82	
T84	CONC 788 798	mortalidad
A4	Assertion T84 Speculated
#78	AnnotatorNotes T84	C0026565; Mortality Vital Statistics; Quantitative Concept
R3	Speculation Arg1:T79 Arg2:T84	
R4	Location_of Arg1:T1 Arg2:T61	
T88	CONC 77 87	mortalidad
#79	AnnotatorNotes T88	C0026565; Mortality Vital Statistics; Quantitative Concept
R6	Overlap Arg1:T88 Arg2:T72	
R8	Overlap Arg1:T11 Arg2:T72	
R9	Experiences Arg1:T73 Arg2:T3	
R11	Experiences Arg1:T73 Arg2:T11	
R12	Experiences Arg1:T73 Arg2:T61	
R13	Location_of Arg1:T6 Arg2:T4	
R14	Location_of Arg1:T7 Arg2:T48	
T89	CONC 282 292	mortalidad
#80	AnnotatorNotes T89	C0085556; Hospital Mortality; Qualitative Concept
R15	Has_Quantifier_or_Qualifier Arg1:T89 Arg2:T8	
R16	Experiences Arg1:T75 Arg2:T48	
R17	Experiences Arg1:T75 Arg2:T4	
R20	Experiences Arg1:T75 Arg2:T9	
R21	Experiences Arg1:T75 Arg2:T10	
R22	Location_of Arg1:T49 Arg2:T9	
R23	Has_Duration_or_Interval Arg1:T9 Arg2:T76	
R24	Has_Duration_or_Interval Arg1:T10 Arg2:T76	
R25	Location_of Arg1:T49 Arg2:T10	
R26	Overlap Arg1:T48 Arg2:T9	
R27	Overlap Arg1:T48 Arg2:T10	
R28	Overlap Arg1:T4 Arg2:T9	
R29	Overlap Arg1:T4 Arg2:T10	
R30	Used_for Arg1:T70 Arg2:T77	
R31	Overlap Arg1:T77 Arg2:T12	
R33	Location_of Arg1:T13 Arg2:T78	
R34	Location_of Arg1:T13 Arg2:T12	
R35	Location_of Arg1:T14 Arg2:T50	
R36	Overlap Arg1:T77 Arg2:T50	
T94	Quantifier_or_Qualifier 517 524	soluble
#82	AnnotatorNotes T94	C1948047; Soluble (qualifier); Qualitative Concept
R37	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T94	
R38	Used_for Arg1:T63 Arg2:T80	
R39	Location_of Arg1:T16 Arg2:T81	
R41	Location_of Arg1:T17 Arg2:T51	
R42	Overlap Arg1:T51 Arg2:T18	
R43	Overlap Arg1:T81 Arg2:T51	
R44	Overlap Arg1:T81 Arg2:T18	
R45	Experiences Arg1:T83 Arg2:T18	
R46	Experiences Arg1:T83 Arg2:T51	
R47	Experiences Arg1:T83 Arg2:T81	
R48	Experiences Arg1:T83 Arg2:T80	
R49	Experiences Arg1:T83 Arg2:T62	
R50	Experiences Arg1:T85 Arg2:T19	
R51	Experiences Arg1:T85 Arg2:T66	
T99	PROC 871 890	Se recogieron datos
#84	AnnotatorNotes T99	C0010995; Data Collection; Research Activity | C0262727; Research data collection; Research Activity
T101	Quantifier_or_Qualifier 891 912	de manera prospectiva
R52	Has_Quantifier_or_Qualifier Arg1:T99 Arg2:T101	
R53	Has_Duration_or_Interval Arg1:T99 Arg2:T86	
R54	Experiences Arg1:T87 Arg2:T21	
T102	CONC 1012 1030	inicio del estudio
#85	AnnotatorNotes T102	C4684789; Study Start; Temporal Concept
R55	Overlap Arg1:T64 Arg2:T102	
R56	Location_of Arg1:T23 Arg2:T64	
R58	Used_for Arg1:T100 Arg2:T26	
R61	Overlap Arg1:T27 Arg2:T53	
R62	Experiences Arg1:T90 Arg2:T53	
R63	Experiences Arg1:T91 Arg2:T54	
T103	Observation 1323 1362	elevados niveles de esclerostina sérica
R64	Location_of Arg1:T28 Arg2:T67	
R65	Experiences Arg1:T91 Arg2:T103	
R66	Before Arg1:T103 Arg2:T54	
T104	CONC 1367 1388	curva de Kaplan-Meier
#86	AnnotatorNotes T104	C1720944; Kaplan-Meier Survival Curves; Quantitative Concept (?)
T105	Observation 1430 1460	aumento de esclerostina sérica
R68	Experiences Arg1:T92 Arg2:T105	
R69	Experiences Arg1:T92 Arg2:T68	
R70	Location_of Arg1:T29 Arg2:T68	
R71	Location_of Arg1:T29 Arg2:T105	
T106	CONC 1464 1482	inicio del estudio
#87	AnnotatorNotes T106	C4684789; Study Start; Temporal Concept
T107	CONC 1497 1519	tasas de supervivencia
#88	AnnotatorNotes T107	C0038954; Survival Rate; Quantitative Concept
T108	CONC 1527 1555	análisis de regresión de Cox
#89	AnnotatorNotes T108	C0010235; Cox Proportional Hazards Models; Quantitative Concept (?)
T109	Quantifier_or_Qualifier 1556 1568	multivariado
#90	AnnotatorNotes T109	C0026777; Multivariate Analysis; Quantitative Concept 
R72	Has_Quantifier_or_Qualifier Arg1:T108 Arg2:T109	
R73	Location_of Arg1:T35 Arg2:T24	
R75	Location_of Arg1:T22 Arg2:T25	
R76	Location_of Arg1:T47 Arg2:T11	
R77	Overlap Arg1:T105 Arg2:T106	
T110	CONC 1752 1765	supervivencia
#91	AnnotatorNotes T110	C0220921; survival aspects; Functional Concept
R78	Experiences Arg1:T95 Arg2:T37	
R79	Experiences Arg1:T95 Arg2:T31	
R81	Experiences Arg1:T95 Arg2:T24	
R82	Experiences Arg1:T95 Arg2:T33	
R83	Location_of Arg1:T40 Arg2:T56	
T111	Observation 1959 1974	morbimortalidad
R84	Experiences Arg1:T97 Arg2:T111	
R85	Experiences Arg1:T97 Arg2:T56	
R86	Experiences Arg1:T97 Arg2:T41	
T112	Quantifier_or_Qualifier 2110 2118	post hoc
R92	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T112	
R93	Experiences Arg1:T98 Arg2:T58	
R94	Location_of Arg1:T45 Arg2:T58	
R95	Experiences Arg1:T98 Arg2:T59	
R96	Overlap Arg1:T46 Arg2:T59	
R5	Overlap Arg1:T80 Arg2:T51	
R7	Overlap Arg1:T80 Arg2:T18	
#81	AnnotatorNotes T4	C4021657; Abnormality of bone mineral density; Anatomical Abnormality
#83	AnnotatorNotes T61	C3887493; Sclerostin Measurement; Laboratory Procedure (?)
#92	AnnotatorNotes T64	C3887493; Sclerostin Measurement; Laboratory Procedure (?)
#93	AnnotatorNotes T67	C3887493; Sclerostin Measurement; Laboratory Procedure (?)
#94	AnnotatorNotes T56	C3887493; Sclerostin Measurement; Laboratory Procedure (?)
#95	AnnotatorNotes T58	C3887493; Sclerostin Measurement; Laboratory Procedure (?)
A5	Experiencer T98 Patient
A6	Experiencer T95 Patient
A7	Experiencer T73 Patient
A8	Experiencer T75 Patient
A9	Experiencer T83 Patient
A10	Experiencer T85 Patient
A11	Experiencer T87 Patient
A12	Experiencer T90 Patient
A13	Experiencer T91 Patient
A14	Experiencer T92 Patient
A15	Experiencer T97 Patient
R10	Has_Result_or_Value Arg1:T67 Arg2:T103	
R18	Has_Result_or_Value Arg1:T68 Arg2:T105	
